BioMed to repurchase or redeem notes in connection with acquisition

By Angela McDaniels

Tacoma, Wash., Oct. 8 – BioMed Realty Trust, Inc.’s operating partnership, BioMed Realty, LP, plans to launch tender offers and consent solicitations for one or more series of its notes or redeem the notes, according to an 8-K filing with the Securities and Exchange Commission.

The issuer has four issues of notes: 3.85% senior notes due 2016, 2.625% senior notes due 2019, 6.125% senior notes due 2020 and 4.25% senior notes due 2022.

The tender offers and/or redemptions will be made at the request of Blackstone Real Estate Partners VIII, which agreed to acquire BioMed Realty Trust for $23.75 per share in an all-cash transaction valued at $8 billion.

BioMed Realty Trust is a San Diego-based real estate investment trust with a focus on laboratory and office space for the life science industry.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.